Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy

Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy

As a clinically approved treatment strategy, chemotherapy-mediated tumor suppression has been compromised, and in spite of introducing various kinds of anticancer drugs, cancer eradication with chemotherapy is still impossible. Chemotherapy drugs have been beneficial in improving the prognosis of ca...

Full description

Bibliographic Details
Main Authors: Mohsen Bagheri, Mohammad Arad Zandieh, Mahshid Daryab, Seyedeh Setareh Samaei, Sarah Gholami, Parham Rahmanian, Sadaf Dezfulian, Mahsa Eary, Aryan Rezaee, Romina Rajabi, Ramin Khorrami, Shokooh Salimimoghadam, Peng Hu, Mohsen Rashidi, Alireza Khodaei Ardakan, Yavuz Nuri Ertas, Kiavash Hushmandi
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Translational Oncology
Subjects:
Oxaliplatin
Targeted delivery
Chemoresistance
Synergistic cancer therapy
Gene and drug delivery
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323002243

Internet

http://www.sciencedirect.com/science/article/pii/S1936523323002243

Similar Items